Relay Therapeutics, Inc. (RLAY)
Nasdaq: RLAY · Biological Products, (No Diagnostic Substances) · Cambridge, MA · filing with the SEC since 2020
Who owns Relay Therapeutics, Inc.
As filed with the SECHolders of 5% or more
5
Fmr LLC holds 10% of COMMON STOCK, as its SCHEDULE 13G/A filed Aug 7, 2026 says.
Directors and officers
11
report now, of 17 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Fmr LLC
SCHEDULE 13G/A · filed Aug 7, 2026 · COMMON STOCK · 9.4% in Aug 6, 2026
Casdin Capital, LLC
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.001 per share · 7.5% in Feb 17, 2026
Perceptive Advisors LLC
SCHEDULE 13G/A · filed Aug 10, 2026 · Common Stock, par value $0.001 per share · 9.99% in Apr 13, 2026
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 17, 2025 · Common Stock · 8.8% in Feb 5, 2025
Commodore Capital LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 per share · 9.9% in Nov 14, 2025
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 7.8% in Aug 14, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 5.47% in Jul 29, 2025
What RLAY reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
39sales
0purchases
22sales on a scheduled plan
4people selling
$13.2Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 30, 2025 to Oct 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 32 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Sb Investment Advisers (Uk) Ltd | 10% owner | 1 | $116M | 0 | 0 | $0 |
| Catinazzo Thomas | Chief Financial Officer | 18 | $5.4M | 13 | 0 | $0 |
| Patel Sanjiv | President and CEO | 6 | $4.5M | 4 | 0 | $0 |
| Bergstrom Donald A | President, R&D | 8 | $2.2M | 3 | 0 | $0 |
| Rahmer Peter | See remarks | 7 | $1.2M | 2 | 0 | $0 |